AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34762527 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia (NOR, 20.9% O2)
Number of subjects: 16
Study 34762527 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia (HYP, 12.0% O2)
Number of subjects: 16
Study 34267066 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 15518
Study 34267066 — intervention group
Group type: COMPARATOR
Intervention: Age group comparison
Number of subjects: 15518
Study 34267066 — intervention group
Group type: COMPARATOR
Intervention: Education level comparison
Number of subjects: 15518
Study 34267066 — intervention group
Group type: COMPARATOR
Intervention: Ethnicity comparison
Number of subjects: 15518
Study 34267066 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection rates
Number of subjects: 15518
Study 35435639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100-300 mg/day)
Number of subjects: 160
Study 35435639 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 160
Study 35435639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 35435639 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label period
Number of subjects: 160
Study 33822363 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional disclosure writing
Number of subjects: 144
Study 33822363 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer helping writing
Number of subjects: 144
Study 33822363 — intervention group
Group type: COMPARATOR
Intervention: Neutral control writing
Number of subjects: 144
Study 33668012 — intervention group
Group type: EXPERIMENTAL
Intervention: CIP (critical inspiratory pressure) group (n = 12)
Number of subjects: 30
Study 33668012 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP60 (60% of maximal inspiratory pressure) group (n = 10)
Number of subjects: 30
Study 33668012 — intervention group
Group type: COMPARATOR
Intervention: Sham group (6 cmH2O; n = 8)
Number of subjects: 30
Study 34153630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 54
Study 34153630 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine
Number of subjects: 54
Study 34153630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine and Esketamine (combined group)
Number of subjects: 54
Study 35803302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory strategy to prevent atelectasis (VESPA) with endotracheal intubation, recruitment maneuver, FiO2 titration (<100%), and PEEP of 8-10 cm H2O
Number of subjects: 76
Study 35803302 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilation (laryngeal mask airway, 100% FiO2, zero PEEP)
Number of subjects: 76
Study 35803302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory strategy to prevent atelectasis (VESPA)
Number of subjects: 76
Study 35803302 — intervention group
Group type: COMPARATOR
Intervention: Standard ventilation (control group)
Number of subjects: 76
Study 34887855 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (30μg)
Number of subjects: 0
Study 34887855 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (7.5μg)
Number of subjects: 0
Study 34887855 — intervention group
Group type: EXPERIMENTAL
Intervention: Matrix M adjuvanted H5N1 vaccine (1.5μg)
Number of subjects: 0
Study 34887855 — intervention group
Group type: COMPARATOR
Intervention: Non-adjuvanted H5N1 vaccine (30μg)
Number of subjects: 0
Study 33554614 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation with pulmonary vein isolation
Number of subjects: 778
Study 33243213 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted education about simulation-based education and patient portrayal skills
Number of subjects: 40
Study 36379652 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care surgery (intraoperative neuronavigation and 5-ALA) + DTI and iUS
Number of subjects: 357
Study 36379652 — intervention group
Group type: COMPARATOR
Intervention: Standard of care surgery (intraoperative neuronavigation and 5-ALA)
Number of subjects: 357
Study 32057546 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive robot-enhanced hand rehabilitation (20 min additional to traditional rehabilitation, 3 times per week for 2 months)
Number of subjects: 33
Study 32057546 — intervention group
Group type: COMPARATOR
Intervention: Traditional hand rehabilitation program (60 min, 3 times per week for 2 months)
Number of subjects: 33
Study 33930091 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention tasks
Number of subjects: 2
Study 33930091 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication reviews
Number of subjects: 2
Study 33930091 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication with patients and healthcare professionals
Number of subjects: 2
Study 34456582 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurb group (received 100mg flurbiprofen during surgery)
Number of subjects: 35
Study 34456582 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving flurbiprofen)
Number of subjects: 35
Study 34456582 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 35
Study 35742615 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training (HICT)
Number of subjects: 13
Study 35742615 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 13
Study 34544393 — intervention group
Group type: EXPERIMENTAL
Intervention: e-health treatment for urinary incontinence
Number of subjects: 496
Study 32872078 — intervention group
Group type: EXPERIMENTAL
Intervention: Yiqi‐Huayu‐Tongsui (YQHYTS) granule
Number of subjects: 72
Study 32872078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 36075809 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of OA and total knee replacement (TKR)
Number of subjects: 193
Study 36075809 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with the decision-making process
Number of subjects: 193
Study 36075809 — intervention group
Group type: EXPERIMENTAL
Intervention: Importance attributed to avoiding surgery
Number of subjects: 193
Study 36075809 — intervention group
Group type: EXPERIMENTAL
Intervention: Importance attributed to time needed to relieve symptoms
Number of subjects: 193
Study 32455853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity physical exercise program (PEG, n = 16)
Number of subjects: 32
Study 32455853 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 16)
Number of subjects: 32
Study 34458670 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cystectomy
Number of subjects: 56
Study 34458670 — intervention group
Group type: COMPARATOR
Intervention: Partial cystectomy
Number of subjects: 56
Study 32600140 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT)
Number of subjects: 486
Study 32600140 — intervention group
Group type: COMPARATOR
Intervention: Standard Dressing
Number of subjects: 486
Study 34708422 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM
Number of subjects: 66
Study 34708422 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM-C
Number of subjects: 66
Study 32105984 — intervention group
Group type: EXPERIMENTAL
Intervention: Praliciguat (soluble guanylate cyclase stimulator)
Number of subjects: 184
Study 35856838 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% brimonidine
Number of subjects: 30
Study 35856838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33549254 — intervention group
Group type: EXPERIMENTAL
Intervention: Good glycemic control (mean glycated hemoglobin < 7%)
Number of subjects: 2285
Study 33549254 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor glycemic control (mean glycated hemoglobin ≥ 7%)
Number of subjects: 2285
Study 35442343 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg IV bolus q 4 hourly for 2 days) in TG2 group
Number of subjects: 74
Study 35442343 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (1 mg IV bolus q 4 hourly for 5 days) in TG5 group
Number of subjects: 74
Study 35442343 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% normal saline, 10 mL IV bolus q 4 hourly) in TG0 group
Number of subjects: 74
Study 35442343 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin in TG2 group
Number of subjects: 74
Study 35442343 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin in TG5 group
Number of subjects: 74
Study 35442343 — intervention group
Group type: COMPARATOR
Intervention: Control in TG0 group
Number of subjects: 74
Study 32803647 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated levels of orthorexic eating behavior (n = 35)
Number of subjects: 197
Study 32803647 — intervention group
Group type: COMPARATOR
Intervention: Low levels of orthorexic eating behavior (n = 35)
Number of subjects: 197
Study 36599365 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Shear Rate Therapy (ISRT)
Number of subjects: 18
Study 36599365 — intervention group
Group type: COMPARATOR
Intervention: Enhanced External Counterpulsation (EECP)
Number of subjects: 18
Study 33612059 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance (dose-escalated 2.5–10mg, 20/28 days per cycle for six months)
Number of subjects: 40
Study 33612059 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 40
Study 33612059 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide maintenance
Number of subjects: 40
Study 33612059 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide maintenance and Observation
Number of subjects: 40
Study 32430450 — intervention group
Group type: EXPERIMENTAL
Intervention: ETC120' (10 mg THC and 200 mg CBD)
Number of subjects: 20
Study 32430450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36176534 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 1179
Study 36176534 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk stratification based on nomogram score
Number of subjects: 1179
Study 36176534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression analysis
Number of subjects: 1179
Study 36176534 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration plot and C-index assessment
Number of subjects: 1179
Study 34111674 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (n = 21)
Number of subjects: 42
Study 34111674 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n = 21)
Number of subjects: 42
Study 32762012 — intervention group
Group type: EXPERIMENTAL
Intervention: IBBR with Acellular Dermal Matrix (ADM)
Number of subjects: 135
Study 32762012 — intervention group
Group type: COMPARATOR
Intervention: IBBR without Acellular Dermal Matrix (ADM)
Number of subjects: 135
Study 35893925 — intervention group
Group type: EXPERIMENTAL
Intervention: 5:2 Intermittent Fasting (IFT)
Number of subjects: 34
Study 35893925 — intervention group
Group type: COMPARATOR
Intervention: Continuous Energy Restriction (CER)
Number of subjects: 34
Study 35893925 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IFT and CER
Number of subjects: 34
Study 33781101 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle-foot orthosis (AFO)
Number of subjects: 39
Study 33781101 — intervention group
Group type: EXPERIMENTAL
Intervention: Laterally wedged insoles (LWI)
Number of subjects: 39
Study 33781101 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AFO and LWI
Number of subjects: 39
Study 35120753 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release pediatric melatonin (PRM)
Number of subjects: 125
Study 35120753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 34934115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 86
Study 34934115 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength exercise program
Number of subjects: 86
Study 34934115 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed exercise program
Number of subjects: 86
Study 34934115 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 86
Study 35395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal glucose infusion (30g glucose and 3g 3-O-methylglucose)
Number of subjects: 10
Study 35395220 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 10
Study 34297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention over 18 months
Number of subjects: 296
Study 34297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass mailings of infographic materials
Number of subjects: 296
Study 35599504 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus proprioception training (PTR-PT)
Number of subjects: 40
Study 35599504 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (PTR-mCIMT)
Number of subjects: 40
Study 35599504 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (PTR)
Number of subjects: 40
Study 32535703 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT)
Number of subjects: 22
Study 32535703 — intervention group
Group type: COMPARATOR
Intervention: Periapical radiograph
Number of subjects: 22
Study 32535703 — intervention group
Group type: COMPARATOR
Intervention: Intrasurgical linear measurements
Number of subjects: 22
Study 32233149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab injections
Number of subjects: 41860
Study 32233149 — intervention group
Group type: COMPARATOR
Intervention: Control periods (121-180, 181-240, 241-300, 301-361 days before index date)
Number of subjects: 41860
Study 34521084 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet nadir <100 × 10^3/?L
Number of subjects: 0
Study 34521084 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet decrease >50% following CRRT initiation
Number of subjects: 0
Study 34521084 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombocytopenia at CRRT initiation
Number of subjects: 0
Study 34521084 — intervention group
Group type: EXPERIMENTAL
Intervention: Low platelet nadir and >50% platelet decrease
Number of subjects: 0
Study 35705194 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 g/day perilla oil (HOI)
Number of subjects: 36
Study 35705194 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day perilla oil (LOI)
Number of subjects: 36
Study 35705194 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 36
Study 35899772 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antiplatelet treatment with 300 mg clopidogrel and 100 mg aspirin
Number of subjects: 1022
Study 35899772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1022
Study 34444549 — intervention group
Group type: EXPERIMENTAL
Intervention: Two nudges
Number of subjects: 4000
Study 32532777 — intervention group
Group type: EXPERIMENTAL
Intervention: Current AE analysis practices
Number of subjects: 64
Study 32532777 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of specialist methods for AE analysis
Number of subjects: 64
Study 32532777 — intervention group
Group type: EXPERIMENTAL
Intervention: Undertaking specialist AE analyses
Number of subjects: 64
Study 32532777 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for guidance on appropriate AE analysis
Number of subjects: 64
Study 32532777 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for training on AE analysis
Number of subjects: 64
Study 36115625 — intervention group
Group type: EXPERIMENTAL
Intervention: USCAP
Number of subjects: 130
Study 36115625 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 130
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at sites cg14866069, cg23666362, cg20045320, cg07839457, cg07677157, cg09615688
Number of subjects: 12300
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at sites cg17086398, cg12619262, cg18424841
Number of subjects: 12300
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at each site
Number of subjects: 12300
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: cg20045320, cg07839457, cg07677157
Number of subjects: 12300
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: cg20045320, cg07839457
Number of subjects: 12300
Study 32697766 — intervention group
Group type: EXPERIMENTAL
Intervention: cg20045320, cg07839457, cg17086398
Number of subjects: 12300
Study 35902662 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal-tDCS (10 min duration, 1.5 mA intensity, targeting Fp3 location)
Number of subjects: 96
Study 35902662 — intervention group
Group type: COMPARATOR
Intervention: tDCS-sham (control group)
Number of subjects: 96
Study 33336223 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower quartile of plasma Aβ42/40 (≤0.103)
Number of subjects: 477
Study 33336223 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower quartile of plasma Aβ42/40 (≤0.103) among APOE ε4 non-carriers
Number of subjects: 477
Study 33336223 — intervention group
Group type: COMPARATOR
Intervention: Upper quartile of plasma Aβ42/40 (>0.123)
Number of subjects: 477
Study 33336223 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma Aβ42/40
Number of subjects: 477
Study 32796301 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosilicate conical implants
Number of subjects: 45
Study 32796301 — intervention group
Group type: COMPARATOR
Intervention: Polymethylmethacrylate (control)
Number of subjects: 45
Study 35998278 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless aortic valve replacement (SuAVR)
Number of subjects: 66
Study 34610939 — intervention group
Group type: EXPERIMENTAL
Intervention: POC urine tenofovir testing and viral load monitoring
Number of subjects: 540
Study 34610939 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (laboratory-based VL testing at months 6 and 12)
Number of subjects: 540
Study 32890770 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based rehabilitation exercise program (HREPro)
Number of subjects: 121
Study 32890770 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 121
Study 34117756 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus atazanavir/ritonavir
Number of subjects: 234
Study 34117756 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus darunavir/ritonavir
Number of subjects: 234
Study 34117756 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate/emtricitabine plus raltegravir
Number of subjects: 234
Study 34117756 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 234
Study 36288885 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) full dose (400 mg TID)
Number of subjects: 40
Study 36288885 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) reduced dose (200 mg TID)
Number of subjects: 40
Study 36288885 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 40
Study 33725978 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Thinking Intervention (CTI)
Number of subjects: 103
Study 33725978 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 103
Study 35605475 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g of glucose
Number of subjects: 72
Study 35605475 — intervention group
Group type: COMPARATOR
Intervention: Stevia-sweetened water (placebo)
Number of subjects: 72
Study 35605475 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress
Number of subjects: 72
Study 35605475 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose consumption
Number of subjects: 72
Study 32748261 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic endurance training on bicycle ergometers, 3 times per week for 40-50 min/session for 26 weeks
Number of subjects: 180
Study 32748261 — intervention group
Group type: COMPARATOR
Intervention: Balance and tone training, 3 times per week for 40-50 min/session for 26 weeks
Number of subjects: 180
Study 32748261 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 180
Study 35383544 — intervention group
Group type: EXPERIMENTAL
Intervention: VRET + attention guidance training (AGT)
Number of subjects: 21
Study 35383544 — intervention group
Group type: COMPARATOR
Intervention: Standard VRET
Number of subjects: 21
Study 32671449 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent infiltration of lidocaine and epinephrine 20 minutes prior to incision.
Number of subjects: 40
Study 32671449 — intervention group
Group type: COMPARATOR
Intervention: Conventional Wise-pattern, inferior pedicle breast reduction (Control group).
Number of subjects: 40
Study 32871585 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT) in first complete remission (CR1)
Number of subjects: 656
Study 32871585 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy-only
Number of subjects: 656
Study 32871585 — intervention group
Group type: EXPERIMENTAL
Intervention: HSCT in CR1 for patients with favorable ELN 2017 risk
Number of subjects: 656
Study 32871585 — intervention group
Group type: EXPERIMENTAL
Intervention: HSCT in CR1 for patients with negative NPM1 minimal residual disease (MRD)
Number of subjects: 656
Study 32871585 — intervention group
Group type: EXPERIMENTAL
Intervention: HSCT in CR1 for patients with KB score >=40
Number of subjects: 656
Study 33840177 — intervention group
Group type: EXPERIMENTAL
Intervention: Intertruncal (IT) approach
Number of subjects: 60
Study 33840177 — intervention group
Group type: COMPARATOR
Intervention: Corner pocket (CP) approach
Number of subjects: 60
Study 33769425 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing distance at AL/2 (35 cm)
Number of subjects: 65
Study 33769425 — intervention group
Group type: COMPARATOR
Intervention: Viewing distance at AL (70 cm)
Number of subjects: 65
Study 34038297 — intervention group
Group type: EXPERIMENTAL
Intervention: S-contact glass
Number of subjects: 30
Study 34038297 — intervention group
Group type: COMPARATOR
Intervention: M-contact glass
Number of subjects: 30
Study 36332503 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided selective peripheral nerve block (PNB)
Number of subjects: 111
Study 36332503 — intervention group
Group type: COMPARATOR
Intervention: Sub-dissociative dose ketamine (SDK)
Number of subjects: 111